コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 0.4; 95% CI, 0.3 to 0.6 for </= 10-year life expectancy).
2 line modified Rankin Scale [mRS] score, life expectancy).
3 plicated these animal findings in humans (US-expectancy).
4 ere length at birth has been related to life expectancy.
5 illness, lives saved, and increases in life expectancy.
6 of healthy life expectancy, and overall life expectancy.
7 have significant dyspnea and shortened life expectancy.
8 ed to depend on broader factors shaping life expectancy.
9 atrophy, paralysis, and have diminished life expectancy.
10 opy), reach age 75 or have <10 years of life expectancy.
11 a(-/-) offspring, but at less than Mendelian expectancy.
12 because of organ shortage and increased life expectancy.
13 scribed only to those with a reasonable life expectancy.
14 gate bilirubin and may present a normal life expectancy.
15 depends on external factors influencing life expectancy.
16 eater morbidity than men despite higher life expectancy.
17 heta phase precession was affected by reward expectancy.
18 tween waitlist and post-transplantation life expectancy.
19 at compromise quality of life and limit life expectancy.
20 y over the past century have focused on life expectancy.
21 ness-to-pay or as income from increased life expectancy.
22 factors associated with differences in life expectancy.
23 e significant comorbidities and limited life expectancy.
24 ury have seen a sharp increase in human life expectancy.
25 ation of SCRs and explicit measures of shock expectancy.
26 erceived limited control and to a short life expectancy.
27 nce, mean age at diagnosis, and average life expectancy.
28 kin of mammalian species with different life expectancies.
29 terventions should target subjective alcohol expectancies.
32 he birth and 6 weeks strategy maximized life expectancy (26.5 years in the HIV-infected group and 61.
34 nt difference in unadjusted or adjusted life expectancy across hospital risk-standardized mortality r
35 h greater longevity, and differences in life expectancy across income groups increased over time.
39 and have more comorbidities and shorter life expectancy, all of which may limit the benefit of ICD th
41 sease progression, quality of life, and life expectancy among individuals with HCV infection and for
42 thin each case-mix stratum, we compared life expectancy among patients admitted to high-performing ho
43 itted to high-performing hospitals with life expectancy among patients admitted to low-performing hos
44 eart disease (CHD), allowing for longer life expectancies and an increasing number who will require n
45 the amygdala central nucleus updates reward expectancies and behaviour in both types of extinction,
46 prefectures with the lowest and highest life expectancies and HALE have widened, from 2.5 to 3.1 year
48 s have seen substantial improvements in life expectancy and access to antimicrobials, especially in l
49 nt today because of recent increases in life expectancy and body mass index (BMI), but this assumptio
51 ON: This census tract-level analysis of life expectancy and cause-specific YLL rates highlights impor
52 It also highlights how mechanisms such as expectancy and empathy, which are seen as inducing music
56 its, and results in meaningful gains in life expectancy and large numbers of years of life saved in e
58 raight lines describe the joint rise of life expectancy and lifespan equality: one for primates and t
61 0.4; 95% CI, 0.3 to 0.8 for </= 5-year life expectancy and OR, 0.4; 95% CI, 0.3 to 0.6 for </= 10-ye
62 n has historically seen improvements in life expectancy and other health indicators, even under stres
64 ty, and mortality to forecast trends in life expectancy and the burden of disability in England and W
65 Reliable estimation of future trends in life expectancy and the burden of disability is crucial for a
66 true effect of Barrett's oesophagus on life expectancy and the efficacy of long-term surveillance re
67 istory parameters like generation time, life expectancy and the variance in lifetime reproductive suc
68 minating in a significantly compromised life expectancy and transformation to aggressive disease.
69 be population-level trends in the adult life expectancy and trends in the residual burden of HIV mort
70 cause mortality varied and gaps between life expectancy and years lived in full health, as measured b
75 disability-adjusted life-years (DALYs), life expectancy, and healthy life expectancy (HALE) in Japan
76 is predicted to increase more than male life expectancy, and in Chile, France, and Greece where the t
77 differences in life expectancy, healthy life expectancy, and life expectancy with disability accordin
78 oject life expectancy, quality-adjusted life expectancy, and lifetime medical costs in order to estim
80 , medications used to reach the target, life expectancy, and patient preferences about treatment.
82 Projections of future mortality and life expectancy are needed to plan for health and social serv
83 er breast cancer survivors with limited life expectancy are not known, and there are important risks;
87 o estimate race- and ethnicity-adjusted life expectancy at 40 years of age by household income percen
88 o estimate gains in the population-wide life expectancy at age 15 years since the introduction of ART
92 hat sacubitril/valsartan would increase life expectancy at an ICER consistent with other high-value a
93 is a greater than 95% probability that life expectancy at birth among men in South Korea, Australia,
95 d age-specific death rates to calculate life expectancy at birth and at age 65 years, and probability
96 ficant heterogeneity among provinces in life expectancy at birth and probability of death at ages 0-1
98 utcomes for Indigenous populations for: life expectancy at birth for 16 of 18 populations with a diff
100 ore than half of the projected gains in life expectancy at birth in women will be due to enhanced lon
101 ge 5 years and from age 15 to 60 years, life expectancy at birth, and cause-specific and age-specific
102 rience an approximately 1-y increase in life expectancy at birth, and that there would be a cumulativ
103 numbers of deaths and in life years and life expectancy at birth, attributable to changes in PM2.5.
104 ortality in adults (age >/=30y), and on life expectancy at birth, in the contiguous United States dur
105 Data were obtained for population, life expectancy at birth, infant mortality, low and high birt
106 onic status gradients for mortality and life expectancy at birth, with outcomes improving with increa
109 particular, some advocate forecasts of life expectancy based on period trends; others favor forecast
112 associated with a 2.1-year reduction in life expectancy between ages 40 and 85 years, the correspondi
113 there was no significant difference in life expectancy between the groups (both 4.2 yrs; P = 0.97).
116 n found to be associated with decreased life expectancy, but little is known about whether this is al
117 -related chronic conditions and reduced life-expectancy, but the underlying biomolecular mechanisms r
118 illion lives and significantly increase life expectancy by 3.1-8.4 years, depending on the country pr
119 matic brain injury (TBI) shortened mean life expectancy by 8.7 years and by as much as 13 years if on
121 n income and life expectancy; trends in life expectancy by income group; geographic variation in life
123 ration data for King County to estimate life expectancy, cause-specific mortality rates, and years of
124 state was defined as the proportion of life expectancy comorbid-free, and was adjusted on the probab
125 shortfall of the population-wide adult life expectancy compared with that of the HIV-negative popula
127 g Mexico back on a track of substantial life expectancy convergence with better performing countries.
129 life-years lived as well as the present life expectancy deficit are almost exclusively due to differe
133 t samples t tests determined whether patient expectancy differed between the open and placebo-control
135 argues that the self-fulfilling prophecy and expectancy effects of descriptive stereotypes are not po
136 ntly demonstrating small or at best moderate expectancy effects, and high accuracy in social percepti
137 ly overstated the power and pervasiveness of expectancy effects, and ignored evidence of accuracy.
138 t with truncated development, shortened life expectancies, elevated mortality rates and higher extinc
139 that temporally discrete cues raising reward expectancy enhance both theta and beta band activity in
142 ios (ICERs), using discounted costs and life expectancies for all HIV-exposed (infected and uninfecte
145 ssumption of limited but precious functional expectancy for an old kidney and substantial reduction o
147 ed a multistate life table to calculate life expectancy for individuals who were normal weight, overw
150 ll MDR patients resulted in the highest life expectancy for our initial cohort averaged across all pa
151 ptors PD-1 and CTLA-4 and have improved life expectancy for patients across a range of tumor types.
152 survive to older ages than males, with life expectancy for the least frail adult females reaching up
153 sing loss of motor function and reduced life expectancy, for which limited treatment is available.
155 smokers aged 40 years lose >6 years of life expectancy from smoking, possibly outweighing the loss f
156 rt, the mean (2.5th, 97.5th percentile) life expectancy from time of initiation of MDR TB treatment a
158 ing aspirin at ages 40 to 69 years, and life expectancy gains are expected for most men and women ini
160 ortality account for 79.7% of the total life expectancy gains in men (8.4 adult life-years), and 90.7
164 wn benefits, whereas 14% with estimated life expectancy > 10 years did not report mammography.
165 We aimed to estimate health-adjusted life expectancy (HALE) among adults living with and without H
167 Driven by technological progress, human life expectancy has increased greatly since the nineteenth ce
170 shaped by reward learning, even after reward expectancies have changed, is less well understood.
171 an imaging studies manipulating attention or expectancy have identified the periaqueductal gray (PAG)
173 level, treating HCV before LT increased life expectancy if MELD was </=27 but could decrease life exp
174 s revealed that increased generalization (US-expectancy), if not prevented, could be reduced by a rem
175 luation of age-specific factors such as life expectancy, impaired functional status, and cognitive de
176 and its neural correlates as well as alcohol expectancies in alcohol-dependent patients and healthy c
177 n consistent with circadian-modulated reward expectancies in neural pathways (i.e., greater activatio
178 ears, the same as the highest worldwide life expectancy in 2012, and a 57% probability that it will b
179 life expectancy exceeded those in male life expectancy in all provinces except Shanghai, Macao, and
181 the remarkable recent history of female life expectancy in Denmark, a saga of rising, stagnating, and
182 T) has improved the immune function and life expectancy in HIV-infected patients whose respiratory al
186 d other factors have contributed to the life expectancy in patients with CML approaching that of the
191 lted in a reduction in life expectancy; life expectancy in Syria would have been 5 years higher than
192 se that contributed most to increase in life expectancy; in particular, they affect mortality at youn
193 ince the roll-out of ART in 2004, adult life expectancy increased by 15.2 years for men (95% CI 12.4-
196 ntia is expected to soar as the average life expectancy increases, but recent estimates suggest that
198 se results suggest that cue-triggered reward expectancy intensifies hippocampal output to target stru
200 lth care is of increasing importance as life expectancy is being prolonged extensively among PLWH.
203 stered, whether a patient's anticipated life expectancy is extraordinary, and whether a patient's ind
204 In particular, the black-white gap in life expectancy is greater at higher levels of educational at
205 sation of mammography in patients whose life expectancy is less than 5 years to 10 years, regardless
206 ery country except Mexico, where female life expectancy is predicted to increase more than male life
209 inked to ART per 1,000 ART initiations, life expectancy (LE, in years) and per-person lifetime HIV-re
210 y income group; geographic variation in life expectancy levels and trends by income group; and factor
211 d Syria have resulted in a reduction in life expectancy; life expectancy in Syria would have been 5 y
212 e now out of date because of changes in life expectancy, living conditions, and health profiles.
213 ancer survivors with an estimated short life expectancy (< 5 years) receive annual surveillance mammo
214 whether between-group differences in patient expectancy mediated the group effect on HAM-D scores.
215 randomized controlled trial whether patient expectancy mediates placebo effects in antidepressant st
216 y, those with >/=20 teeth had a longer life expectancy (men: +57 d; women: +15 d) and healthy life e
217 (men: +57 d; women: +15 d) and healthy life expectancy (men: +92 d; women: +70 d) and a shorter life
219 imately 8.6% and 35.1% had an estimated life expectancy of </= 5 and </= 10 years, respectively.
220 on admission was associated with longer life expectancy of 0.78 (standard error [SE]: 0.05), 0.55 (SE
221 x 10(-7)) translating to a reduction in life expectancy of 2.9 years for males and 2.6 years for fema
222 t care), the no EID strategy produced a life expectancy of 21.1 years (in the HIV-infected group) and
224 ally measurable disease (by CT or MRI); life expectancy of 6 months or more; adequate haematological
227 at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take
228 at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take
229 function and laboratory test results, a life expectancy of at least 12 weeks, and having recovered fr
230 ogy Group performance status of 0 or 1, life expectancy of at least 3 months, and at least one measur
232 lity of life, and quality-adjusted life year expectancy of cancer patients admitted to the ICU are li
235 IV disease and treatment to project the life expectancy of HIV-infected persons, based on smoking sta
238 assessed how these changes affected the life expectancy of patients with CML and life-years lost as a
239 kemia (CML) treatment, transforming the life expectancy of patients; however the risk for relapse rem
244 f mammography decreased with decreasing life expectancy ( P < .001), although 56.7% and 65.9% of thos
245 ng measurement of pre- and postrandomization expectancy, participants were treated with citalopram or
246 by age group and cause, and forecasted life expectancy pathways for Mexico to converge to better per
247 through 12 months were used to project life expectancy, quality-adjusted life expectancy, and lifeti
254 o smoke lost 6.7 years and 6.3 years of life expectancy, respectively, compared with never smokers; t
255 th estimated </= 5-year and </= 10-year life expectancy, respectively, reported mammography in the la
256 VS and lead to reduced updating of treatment expectancies, resulting in less extinction of placebo hy
257 compared these strategies according to life expectancy, risks of acquired resistance, and the expect
262 udes multiple failed replications of classic expectancy studies, meta-analyses consistently demonstra
263 Long-standing racial differences in US life expectancy suggest that black Americans would be exposed
264 sm and the likely role of inaccurate outcome expectancies support the importance of smoking cessation
265 ving with HIV, had much shorter overall life expectancies than did their HIV-negative counterparts in
266 acute myocardial infarction had longer life expectancies than patients treated in low-performing hos
268 der cessation while taking into account life expectancy, the estimated risk for subsequent in-breast
269 S to increased disease risk and reduced life expectancy, the underlying biology remains poorly unders
272 ast national age-specific mortality and life expectancy using an approach that takes into account the
273 in the last 12 months by 5- and 10-year life expectancy (using the validated Schonberg index), adjust
275 ue updating were separable from responses to expectancy violation, and that reducibility of uncertain
276 to make better decisions while ignoring mere expectancy violation.SIGNIFICANCE STATEMENT To make good
277 ized by a Bayesian model where agents ignore expectancy violations that do not update beliefs or valu
279 rship on social perception and interpersonal expectancies was characterized by a tripartite pattern:
282 c.1903C>T lived longer than the others, life expectancy was greatly diminished (10.8 vs. 4.6 months).
283 In adjusted analyses, lower ( v higher) life expectancy was significantly associated with lower odds
289 der-patient discussions about prognosis/life expectancy were examined for their association with chan
290 obability that by 2030, national female life expectancy will break the 90 year barrier, a level that
291 men: +92 d; women: +70 d) and a shorter life expectancy with disability (men: -35 d; women: -55 d) co
292 xpectancy, healthy life expectancy, and life expectancy with disability according to the number of te
293 on of morbidity: older Japanese adults' life expectancy with disability was compressed by 35 to 55 d
295 morbidity, measured as a shortening of life expectancy with disability, an extension of healthy life
296 report recent discussions of prognosis/life expectancy with their oncologists come to have a better
298 ed only recent discussions of prognosis/life expectancy with their oncologists; 68 (38%) reported onl
299 h HCM can achieve normal or near-normal life expectancy without disability, and usually do not requir
300 re externalizing behaviors, positive alcohol expectancies), worse executive functioning, and thinner
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。